• RESEARCH

    CEMIP identified as candidate biomarker in early-onset colorectal cancer

    Researchers identified CEMIP as elevated in colorectal cancer diagnosed before age 50 and associated with poorer overall survival, with evidence linking it to PTCH1-related Hedgehog signaling pathways. (Genes)